5Li TZ, Kim JH, Cho HH, et al. Therapeutic potential of bone-marrow- derived mesenchymal stem cells differentiated with growth-factor-free coculture method in liver-injured rats [ J ]. Tissue E ng Part A,2010,16 ( 8 ) :2649-2659.
6Stutchfield BM, Forbes SJ, Wigmore SJ. Prospects for stem cell trans- plantation in the treatment of hepatic disease . Liver Transpl,2010, 16(7) :827-836.
7Kisseleva T, Gigante E, Brenner DA. Recent advances in liver stem cell therapy [ J]. Curt Opin Gastroentero1,2010,26 (4) :395-402.
8Madhava P, Zaeharoulis D, Miroslav N, et al. Autologous Infusion of expanded mobilized adult bone marrow-derived CD34 + cells into pa- tients with alcoholic liver cirrhosis [ J ]. Am J Gastroenter, 2008,103 (8) :1952-1958.
9Gilchrist ES, Plevris JN. Bone marrow-derived stem cells in liver re- pair: 10 years down the line [ J ]. Liver Transpl, 2010, 1 6 : 11 8-129.
10Zhang L, Peng X,Zhang Z, et al. Subcellular proteome analysis unrav- eled annexin A2 related to immune liver fibrosis[ J]. J Cell Biochem, 2010,110( 1 ) :219-228.
